PLCD4

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, PLCD4 mutation is significantly associated with the RNA expression of many other genes, with 4,446 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible PLCD4-associated genes across cancer lineages are RNA5SP277, MIR1183, and GLYATL3. Each is linked with PLCD4 in more than 1 cancer types. Because this analysis shows association rather than direction, both PLCD4-to-partner and partner-to-PLCD4 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP277 grouped by PLCD4-low versus PLCD4-high in HNSC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PLCD4→partner) and Y-score (partner→PLCD4) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCRNA5SP277 →+0.504+5.303<.001.00632
HNSCMIR1183 →+0.737+5.736<.001.00332
UCECGLYATL3 →+0.823+1.360<.001.00632
UCECADAM33 →-0.699-3.034.001<.00132
LUADPMM2P1 →+0.126+4.798<.001.00632
CESCLINC02876 →+0.083+5.010<.001.00932
Each partner links to its Q-omics profile. Showing the 6 strongest of 4,446 associations by consensus.

RNA5SP277 by PLCD4 expression — HNSC

Box plot of RNA5SP277 in PLCD4-low vs PLCD4-high samples in HNSC.

Explore this box plot interactively →

Exploration